Regulatory

Regulatory  ·  Weekly Digest 18 Jan to 24 Jan 2025
Zai Lab receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the treatment of Small Cell Lung Cancer (SCLC)

Weekly Digest – January 2025 Weekly Digest – January 2025 22 Jan 2025: Zai Lab receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the treatment of Small Cell Lung Cancer (SCLC) Zai Lab’s First-in-class DLL3-targeting […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 18 Jan to 24 Jan 2025
YL201 received another Breakthrough Therapy Designation for the treatment of R/M Nasopharyngeal Carcinoma

Weekly Digest – January 2025 Weekly Digest – January 2025 20 Jan 2025: YL201 received another Breakthrough Therapy Designation for the treatment of R/M Nasopharyngeal Carcinoma MediLink receives CDE Breakthrough Therapy Designation for YL201 for recurrent/metastatic nasopharyngeal carcinoma following prior […]

by Sandhya Ramalingam

Continue Reading